XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Compensation and Benefit Plans (Tables)
9 Months Ended
Sep. 30, 2022
Compensation And Retirement Disclosure [Abstract]  
Summary of ESOP Shares

A summary of the ESOP shares as of September 30, 2022 and December 31, 2021 are as follows:

 

 

 

September 30, 2022

 

 

December 31, 2021

 

 

 

(Dollars in thousands)

 

Shares committed-to-be released

 

 

105,357

 

 

 

96,500

 

Shares allocated to participants

 

 

363,261

 

 

 

170,145

 

Unallocated shares

 

 

1,597,863

 

 

 

434,251

 

Total

 

 

2,066,481

 

 

 

700,896

 

Fair value of unallocated shares

 

$

14,636

 

 

$

6,297

 

Schedule of Restricted Stock Units Awards Activity and Related Information

A summary of the Company’s restricted stock unit awards activity and related information for nine months ended September 30, 2022 and year ended December 31, 2021 are as follows:

 

 

 

September 30, 2022

 

 

 

Number
of Shares

 

 

Weighted-
Average
Grant Date
Fair Value
Per Share

 

Non-vested, beginning of year

 

 

237,687

 

 

$

12.65

 

Conversion and reorganization

 

 

93,933

 

 

 

 

Granted

 

 

 

 

 

 

Vested

 

 

(12,440

)

 

 

9.27

 

Forfeited

 

 

 

 

 

 

Non-vested at March 31

 

 

319,180

 

 

$

9.06

 

Granted

 

 

63,715

 

 

 

10.44

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Non-vested at June 30

 

 

382,895

 

 

$

9.29

 

Granted

 

 

 

 

 

 

Vested

 

 

(4,186

)

 

 

7.20

 

Forfeited

 

 

 

 

 

 

Non-vested at September 30

 

 

378,709

 

 

$

9.31

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

 

Number
of Shares

 

 

Weighted-
Average
Grant Date
Fair Value
Per Share

 

Non-vested, beginning of year (1)

 

 

335,919

 

 

$

12.66

 

Granted

 

 

 

 

 

 

Vested

 

 

(98,232

)

 

 

12.69

 

Forfeited

 

 

 

 

 

 

Non-vested at December 31

 

 

237,687

 

 

$

12.65

 

Schedule of Stock Option Awards Activity and Related Information

A summary of the Company’s stock option awards activity and related information for nine months ended September 30, 2022 and year ended December 31, 2021 are as follows:

 

 

 

September 30, 2022

 

 

 

Options

 

 

Weighted-
Average
Exercise
Price
Per Share

 

Outstanding, beginning of year

 

 

203,766

 

 

$

12.02

 

Conversion and reorganization

 

 

80,526

 

 

 

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at March 31

 

 

284,292

 

 

 

8.62

 

Granted

 

 

68,329

 

 

 

10.44

 

Exercised

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at June 30

 

 

352,621

 

 

 

8.97

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at September 30 (1)

 

 

352,621

 

 

$

8.97

 

Exercisable at September 30 (1)

 

 

147,301

 

 

$

8.74

 

 

 

 

 

December 31, 2021

 

 

 

Options

 

 

Weighted-
Average
Exercise
Price
Per Share

 

Outstanding, beginning of year

 

 

203,766

 

 

$

12.02

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at December 31 (1)

 

 

203,766

 

 

$

12.02

 

Exercisable at December 31 (1)

 

 

94,904

 

 

$

12.45

 

(1)
The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at respective periods and the stated exercise price of the underlying options, was $67,000 for outstanding options and $62,000 for exercisable options at September 30, 2022 and was $505,000 for outstanding options and $195,000 or exercisable options December 31, 2021.
Schedule of Fair Value of Option Grant Using Black-Scholes Option Pricing Model With Weighted Average Assumptions

The fair value of each option grant is estimated on the date of grant using Black-Scholes option pricing model with the following weighted average assumptions:

 

 

For the Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

Dividend yield

 

 

0.00

%

 

 

0.00

%

Expected life

 

6.5 years

 

 

6.5 years

 

Expected volatility

 

 

41.34

%

 

 

38.51

%

Risk-free interest rate

 

 

2.65

%

 

 

0.48

%

Weighted average grant date fair value

 

$

3.85

 

 

$

3.77